Collegium Pharmaceutical, Inc.

Collegium Pharmaceutical Misses on EPS, Stock Up 2.27%

Collegium Pharmaceutical's earnings report showed a significant miss on EPS, which typically raises concerns among investors. However, the stock reacted positively, rising by 2.27%. This could indicate that investors are optimistic about other aspects of the company's performance or future potential, despite the disappointing EPS figure.